Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-27 @ 11:41 PM
Study NCT ID:
NCT06757894
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-01-03
First Post:
2024-12-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2034-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-27
First Submit QC Date:
None
Study First Post Date:
2025-01-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-28
Last Update Post Date:
2025-01-03
Last Update Post Date Type:
ACTUAL